PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för tafluprost. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

14 hits

Bibliografisk träff 2012-08-03

Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets.

Nakagawa S, Usui T, Yokoo S, Omichi S, Kimakura M, Mori Y, Miyata K, Aihara M, Amano S, Araie M.

Invest Ophthalmol Vis Sci · journal article · DOI 10.1167/iovs.12-9685

Bibliografisk träff 2012-06-13

Efficacy and ocular surface tolerability of preservative-free tafluprost 0.0015%: a 6-month, single-blind, observational study on naïve ocular hypertension or glaucoma patients.

Rossi GC, Pasinetti GM, Raimondi M, Ricciardelli G, Scudeller L, Blini M, Amisano A, Bianchi PE.

Expert Opin Drug Saf · journal article · DOI 10.1517/14740338.2012.690734

Bibliografisk träff 2012-06-07

Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects.

Kawaguchi I, Higashide T, Ohkubo S, Kawaguchi C, Sugiyama K.

Jpn J Ophthalmol · comparative study; randomized controlled trial; journal article · DOI 10.1007/s10384-012-0155-2

Bibliografisk träff 2012-05-14

Drug metabolite heterogeneity in cultured single cells profiled by pico-trapping direct mass spectrometry.

Fukano Y, Tsuyama N, Mizuno H, Date S, Takano M, Masujima T.

Nanomedicine (Lond) · research support, non-u.s. gov't; journal article · DOI 10.2217/nnm.12.34

Bibliografisk träff 2012-05-07

Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma.

Ermiş SS.

Clin Ophthalmol · review-article; journal article · DOI 10.2147/opth.s24248

Bibliografisk träff 2012-04-19

A prospective study evaluating IOP changes after switching from a therapy with prostaglandin eye drops containing preservatives to nonpreserved tafluprost in glaucoma patients.

Ranno S, Sacchi M, Brancato C, Gilardi D, Lembo A, Nucci P.

ScientificWorldJournal · other; comparative study; clinical trial; journal article · DOI 10.1100/2012/804730

Bibliografisk träff 2012-04-01

Tafluprost (Zioptan) - a new topical prostaglandin for glaucoma.

Författaruppgift saknas

Med Lett Drugs Ther · journal article

Bibliografisk träff 2012-03-07

Spanish multicenter tafluprost tolerability study.

Milla E, Stirbu O, Rey A, Duch S, Buchacra O, Robles A, Navarro C, Gil R, Cordero JM.

Br J Ophthalmol · clinical trial; multicenter study; journal article · DOI 10.1136/bjophthalmol-2011-301015

Bibliografisk träff 2012-02-04

Randomized clinical trial of the efficacy and safety of preservative-free tafluprost and timolol in patients with open-angle glaucoma or ocular hypertension.

Chabi A, Varma R, Tsai JC, Lupinacci R, Pigeon J, Baranak C, Noble L, Lines C, Ho TW.

Am J Ophthalmol · clinical trial, phase iii; comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.1016/j.ajo.2011.11.008

Bibliografisk träff 2012-02-01

Ocular hypotensive effect of tafluprost in latanoprost low-responder cynomolgus monkeys.

Kurashima H, Asai Y, Aihara M, Ishida N, Nakamura M, Araie M.

J Glaucoma · journal article · DOI 10.1097/ijg.0b013e31820bc9ce

Bibliografisk träff 2012-01-12

Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma.

Janulevičienė I, Derkač I, Grybauskiene L, Paulauskaitė R, Gromnickaite R, Kuzmienė L.

Clin Ophthalmol · research-article; journal article · DOI 10.2147/opth.s28104

Bibliografisk träff 2011-11-22

In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.

Choi HY, Lee JE, Lee JW, Park HJ, Lee JE, Jung JH.

J Ocul Pharmacol Ther · research support, non-u.s. gov't; research-article; journal article · DOI 10.1089/jop.2011.0160

Bibliografisk träff 2011-11-03

The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.

Pellinen P, Huhtala A, Tolonen A, Lokkila J, Mäenpää J, Uusitalo H.

Curr Eye Res · research support, non-u.s. gov't; journal article · DOI 10.3109/02713683.2011.626909

Bibliografisk träff 2011-04-14

Metabolism and ocular tissue distribution of an antiglaucoma prostanoid, tafluprost, after ocular instillation to monkeys.

Fukano Y, Kawazu K, Akaishi T, Bezwada P, Pellinen P.

J Ocul Pharmacol Ther · journal article · DOI 10.1089/jop.2010.0178